286 related articles for article (PubMed ID: 11948419)
21. Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway.
Koul D; Yao Y; Abbruzzese JL; Yung WK; Reddy SA
J Biol Chem; 2001 Apr; 276(14):11402-8. PubMed ID: 11278366
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.
Sano T; Lin H; Chen X; Langford LA; Koul D; Bondy ML; Hess KR; Myers JN; Hong YK; Yung WK; Steck PA
Cancer Res; 1999 Apr; 59(8):1820-4. PubMed ID: 10213484
[TBL] [Abstract][Full Text] [Related]
23. Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN.
Agrawal S; Pilarski R; Eng C
Hum Mol Genet; 2005 Aug; 14(16):2459-68. PubMed ID: 16014636
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase.
Morimoto AM; Berson AE; Fujii GH; Teng DH; Tavtigian SV; Bookstein R; Steck PA; Bolen JB
Oncogene; 1999 Feb; 18(6):1261-6. PubMed ID: 10022807
[TBL] [Abstract][Full Text] [Related]
25. [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)].
Soussi T
Bull Cancer; 1999 Sep; 86(9):715-6. PubMed ID: 10576807
[No Abstract] [Full Text] [Related]
26. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.
Wishart MJ; Dixon JE
Trends Cell Biol; 2002 Dec; 12(12):579-85. PubMed ID: 12495846
[TBL] [Abstract][Full Text] [Related]
27. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells.
Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB
Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942
[TBL] [Abstract][Full Text] [Related]
28. Direct identification of PTEN phosphorylation sites.
Miller SJ; Lou DY; Seldin DC; Lane WS; Neel BG
FEBS Lett; 2002 Sep; 528(1-3):145-53. PubMed ID: 12297295
[TBL] [Abstract][Full Text] [Related]
29. PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow.
Haier J; Nicolson GL
Oncogene; 2002 Feb; 21(9):1450-60. PubMed ID: 11857088
[TBL] [Abstract][Full Text] [Related]
30. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.
Lin H; Bondy ML; Langford LA; Hess KR; Delclos GL; Wu X; Chan W; Pershouse MA; Yung WK; Steck PA
Clin Cancer Res; 1998 Oct; 4(10):2447-54. PubMed ID: 9796977
[TBL] [Abstract][Full Text] [Related]
31. Association between DNA content and tumor suppressor gene expression and aggressiveness of atypical teratoid/rhabdoid tumors.
Berrak SG; Ozek MM; Canpolat C; Dağçinar A; Sav A; El-Naggar A; Langford LA
Childs Nerv Syst; 2002 Oct; 18(9-10):485-91. PubMed ID: 12382173
[TBL] [Abstract][Full Text] [Related]
32. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
34. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.
Lee JO; Yang H; Georgescu MM; Di Cristofano A; Maehama T; Shi Y; Dixon JE; Pandolfi P; Pavletich NP
Cell; 1999 Oct; 99(3):323-34. PubMed ID: 10555148
[TBL] [Abstract][Full Text] [Related]
36. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.
Furnari FB; Huang HJ; Cavenee WK
Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298
[TBL] [Abstract][Full Text] [Related]
37. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
38. PTEN: life as a tumor suppressor.
Simpson L; Parsons R
Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
[TBL] [Abstract][Full Text] [Related]
39. Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
Bianco R; Shin I; Ritter CA; Yakes FM; Basso A; Rosen N; Tsurutani J; Dennis PA; Mills GB; Arteaga CL
Oncogene; 2003 May; 22(18):2812-22. PubMed ID: 12743604
[TBL] [Abstract][Full Text] [Related]
40. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
